Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 2:323:198953.
doi: 10.1016/j.virusres.2022.198953. Epub 2022 Oct 7.

Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt

Affiliations

Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt

Alshymaa A Hassnine et al. Virus Res. .

Abstract

Background: Chronic hepatitis B (HBV) and C virus (HCV) infections represent significant public health issues internationally. HBV vaccination has high sero-conversion rates in patients with mild to moderate chronic liver disease but has reduced efficacy in advanced stages.

Aim: to evaluate the efficacy of hepatitis B vaccination in HCV-related chronic liver disease and identify possible factors that may contribute to hypo-responsiveness in those patients.

Methods: Our study was a retrospective observational clinical study carried out at the tropical medicine department. It was conducted on 500 individuals (400 chronic HCV patients and 100 healthy controls). Individuals were divided into 5 groups: A (control group), B (cirrhotic patient not receiving treatment), C (chronic hepatitis patients receiving treatment), D (cirrhotic patients receiving treatment), and E (HCC patients receiving treatment). All individuals were subjected for comprehensive history taking, clinical examination, laboratory investigations, and assessment of anti-HBs titer.

Results: There is an inverse relationship between the level of anti-HBs Abs and the duration of vaccine. Diabetes and presence of cirrhosis have statistically significant relationship with serum anti-HBs Abs titer (P = 0.007). Oral DAAs therapy is associated with reduced response to HBV vaccine (only 31.75% of the patients were protected).

Conclusion: HCV infection and its complications significantly impair HBV vaccine response. Levels of anti-HBs Abs decline progressively with increasing duration from the last dose in immunization schedule of HBV vaccine. Diabetes and presence of cirrhosis being the main risk factors for vaccine hypo-responsiveness, also oral DAAs therapy is associated with reduced response to HBV vaccine.

Keywords: Chronic hepatitis B; DAAs; HCV; Liver cirrhosis; Vaccine response.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interests All authors declare no Conflict of interest

Figures

Fig 1
Fig. 1
Percentage of protected individuals vs. non-protected individuals in each studied group.
Fig 2
Fig. 2
Relation between serum anti-HBs Abs titer vs. the duration of HBV vaccination for all studied individuals.

References

    1. Konstantinou D., Deutsch M. The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management. Ann. Gastroenterol. 2015;28(Issue 2):221. - PMC - PubMed
    1. World Health Organization Accelerating access to hepatitis C diagnostics and treatment: overcoming barriers in low- and middle-income countries. Global Progr. Rep. 2020 2021 [cited 2021 Jul 20]
    1. Karoney M.J., Siika A.M. Hepatitis C virus (HCV) infection in Africa: a review. Pan. Afr. Med. J. 2013;Volume 14(Issue 1) - PMC - PubMed
    1. Zoulim F., Mason W.S. BMJ Publishing Group; 2012. Reasons to Consider Earlier Treatment of Chronic HBV Infections. - PubMed
    1. Wei, W. Noninvasive Evaluation of Liver Fibrosis Reverse Using Artificial Neural Network Model for Chronic Hepatitis B Patients. Computational and mathematical methods in medicine, 2019. - PMC - PubMed

LinkOut - more resources